Cargando…

Biologics for the Treatment of Severe Acrodermatitis Continua of Hallopeau: Report of Two Cases Successfully Treated with Ixekizumab and Ustekinumab

Detalles Bibliográficos
Autores principales:	Gargiulo, Luigi, Toso, Francesco, Ibba, Luciano, Valenti, Mario, Costanzo, Antonio, Narcisi, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188160/ https://www.ncbi.nlm.nih.gov/pubmed/37196286 http://dx.doi.org/10.5826/dpc.1302a103

Ejemplares similares

Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report
por: Battista, Teresa, et al.
Publicado: (2022)

Ixekizumab for the Treatment of Acrodermatitis Continua of Hallopeau and Inverse Psoriasis
por: Xia, Rui Yuan, et al.
Publicado: (2023)

Acrodermatitis Continua of Hallopeau Successfully Treated with Ustekinumab: A Case Report and Literature Review
por: Shi, Liping, et al.
Publicado: (2023)

Dermoscopy of Acrodermatitis Continua of Hallopeau
por: Mittal, Setu, et al.
Publicado: (2022)

Acrodermatitis continua of Hallopeau: clinical perspectives
por: Smith, Mary Patricia, et al.
Publicado: (2019)

Pustular Psoriasis of Pregnancy with Acrodermatitis Continua of Hallopeau
por: Shah, Akanksha, et al.
Publicado: (2016)

Acrodermatitis Continua of Hallopeau: A Diagnostic Challenge
por: Mitra, Debdeep, et al.
Publicado: (2022)

Acrodermatitis continua of Hallopeau successfully treated with adalimumab: A case report
por: Crowley, Erika L, et al.
Publicado: (2019)

Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report
por: Cirone, Katrina D, et al.
Publicado: (2023)

Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature
por: Galluzzo, Marco, et al.
Publicado: (2019)

Successful treatment of acrodermatitis continua of Hallopeau with tildrakizumab: A case report
por: Nguyen, Alex, et al.
Publicado: (2023)

Acrodermatitis Continua of Hallopeau Evolving into Generalised Pustular Psoriasis
por: Ranugha, Poovanur SS, et al.
Publicado: (2013)

Clinico-Pathological and Dermoscopic Features in Acrodermatitis Continua of Hallopeau
por: Taneja, Gargi, et al.
Publicado: (2021)

Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option?
por: Megna, Matteo, et al.
Publicado: (2022)

Successful Treatment of Acrodermatitis Continua of Hallopeau with an Anti-IL-17A Agent
por: Inoue, Sae, et al.
Publicado: (2021)

Acrodermatitis continua of Hallopeau and geographic tongue are variants of pustular psoriasis
por: Sadlier, Muriel
Publicado: (2018)

A Case of Acrodermatitis Continua of Hallopeau Following Chronic Pustular Cheilitis
por: Arisi, Mariachiara, et al.
Publicado: (2016)

Outcomes of various types of therapy in patients with treatment-resistant acrodermatitis continua of Hallopeau
por: Smirnova, LM, et al.
Publicado: (2019)

Treatment and molecular profiling of acrodermatitis continua of Hallopeau during pregnancy using targeted therapy
por: Al-Khawaga, Sara, et al.
Publicado: (2021)

Acrodermatitis of Hallopeau and erosive oral mucositis successfully treated with secukinumab
por: Baron, Jennifer A.
Publicado: (2017)

Acrodermatitis Continua of Hallopeau with Bone Resorption in an 8-Year-Old Patient: A Case Report
por: Alorainy, May, et al.
Publicado: (2017)

Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort
por: Assan, F., et al.
Publicado: (2022)

Speckled variance optical coherence tomography for the assessment of nail involvement in acrodermatitis continua of Hallopeau: A case study
por: Conti, Andrea, et al.
Publicado: (2016)

Sub‐erythrodermic psoriasis successfully treated with bimekizumab: A case report
por: Valenti, Mario, et al.
Publicado: (2022)

A rare case of Acrodermatitis continua of Hallopeau successfully treated with topical calcipotriol/betamethasone dipropionate ointment associated with Jaccaud’s arthropathy: A case report
por: Ngo, Jennifer Lavina, et al.
Publicado: (2022)

Acrodermatitis Continua of Hallopeau Evolving into Generalized Pustular Psoriasis Following COVID‐19: A Case Report of a Successful Treatment with Infliximab in Combination with Acitretin
por: Samotij, Dominik, et al.
Publicado: (2021)

Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study
por: Cortese, Andrea, et al.
Publicado: (2023)

Case Report: Paradoxical acrodermatitis of Hallopeau-like eruption following anti-IL-17 therapy
por: Tadiotto Cicogna, Giulia, et al.
Publicado: (2019)

Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study
por: Gargiulo, Luigi, et al.
Publicado: (2023)

Real-Life Safety and Effectiveness of Dupilumab in Patients with Concomitant Malignancies: a Case Series
por: Gargiulo, Luigi, et al.
Publicado: (2023)

What Can IBD Specialists Learn from IL-23 Trials in Dermatology?
por: Valenti, Mario, et al.
Publicado: (2022)

Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study
por: Gargiulo, Luigi, et al.
Publicado: (2022)

Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study
por: Gargiulo, Luigi, et al.
Publicado: (2022)

A Case of Acrodermatitis Continua Accompanying with Osteolysis and Atrophy of the Distal Phalanx That Evoluted into Generalized Pustular Psoriasis
por: Kim, Kyung Ho, et al.
Publicado: (2016)

A case of pediatric psoriasis successfully and rapidly treated with ixekizumab
por: Megna, Matteo, et al.
Publicado: (2021)

Low Level Light Could Work on Skin Inflammatory Disease: A Case Report on Refractory Acrodermatitis Continua
por: Choi, Mira, et al.
Publicado: (2011)

Integrated safety analysis of treatment‐emergent eczematous reactions in patients with moderate‐to‐severe psoriasis treated with ixekizumab, etanercept and ustekinumab
por: Brunner, P.M., et al.
Publicado: (2021)

An Analysis of Patient-reported Outcomes in IXORA-S: Comparing Ixekizumab and Ustekinumab over 52 Weeks in Moderate-to-severe Psoriasis
por: PUIG, Lluís, et al.
Publicado: (2020)

Emerging treatments in the management of psoriasis: biological targeting with ustekinumab
por: Papoutsaki, Marina, et al.
Publicado: (2009)

Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab
por: Hanfstingl, Kathrin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_doq21ovk1u9bnacsmeoocg3mq4